Publication at First Faculty of Medicine |
2013
Abstract
Comment on the article: Legendre CM, Licht C, Muus P et al. Terminal complement inhibitor eculizumab in atypical hemolytic‑uremic syndrome.
N Eng J Med 2013;368:2169‑2181.
Comment on the article: Legendre CM, Licht C, Muus P et al. Terminal complement inhibitor eculizumab in atypical hemolytic‑uremic syndrome.
N Eng J Med 2013;368:2169‑2181.